AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Research | Open Access

Icariin protects against intracerebral hemorrhage in mice by enhancing neuroprotection

Aigerim Bizhanovaa,b, Xiangyu Zhanga,b, Maham Mazhara,b, Yuanyuan Liua,b, Gaili Yana,b, Sara Xuec, V. Wee Yongc( ), Mengzhou Xuea,b( )
Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450001, Henan, China
Academy of Medical Science, Zhengzhou University, Zhengzhou, 450001, Henan, China
Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary T2N 4N1, Alberta, Canada
Show Author Information
An erratum to this article is available online at:

Abstract

Background

Intracerebral hemorrhage (ICH) is a major type of stroke associated with high rates of mortality and long-term disability, often leading to inflammation, brain edema, and neuronal loss. Icariin (ICA) is the primary active compound extracted from Herba epimedii, and it possesses several pharmacological effects including anti-inflammatory, antioxidant and anti-apoptotic properties. However, its neuroprotective capacity and mechanisms in ICH remain unknown. This study investigates the neuroprotective potential of ICA in an ICH mouse model.

Methods

A total of 108 C57BL/6 mice were randomly assigned to three groups: sham group (n = 36), ICH + vehicle group (n = 36), and ICH + ICA group (n = 36). ICH was induced in the ICH + Vehicle and ICH + ICA groups through injection of collagenase type Ⅶ into the basal ganglia. The ICH + ICA group was administered ICA (60 mg/kg/day) intraperitoneally for three consecutive days. Neurological assessment was conducted using the corner test and modified neurological severity scores. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling) staining was performed to evaluate brain cell death. Brain water content, Western blot, Evans blue (EB) dye extravasation, and immunofluorescence staining were conducted 3 days post-ICH.

Results

ICA treatment significantly alleviated brain edema and enhanced neurological function in mice three days post-ICH. Immunofluorescence results revealed that ICA decreased microglia and astrocyte activation and reduced neutrophil infiltration. Western blot results demonstrated that ICA maintained blood-brain barrier (BBB) integrity by decreasing the loss of tight junction proteins, including Occludin and Zonula occludens-1. ICA also lowered matrix metalloproteinase-9 and the proinflammatory cytokines tumor necrosis factor-α and interleukin-1β. TUNEL staining showed a reduction in neuronal cell death with ICA, linked to enhanced level of the anti-apoptotic B-cell lymphoma 2 (Bcl-2) protein and reduced expression of the pro-apoptotic Bcl-2-associated X (Bax) protein.

Conclusion

ICA exhibits significant neuroprotective effects in mice following ICH by reducing neuroinflammation, maintaining BBB integrity, and attenuating brain cell death.

References

【1】
【1】
 
 
Journal of Neurorestoratology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Bizhanova A, Zhang X, Mazhar M, et al. Icariin protects against intracerebral hemorrhage in mice by enhancing neuroprotection. Journal of Neurorestoratology, 2025, 13(5). https://doi.org/10.1016/j.jnrt.2025.100224

1379

Views

0

Crossref

1

Web of Science

0

Scopus

Received: 27 March 2025
Revised: 26 April 2025
Accepted: 06 May 2025
Published: 01 October 2025
© 2025 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).